How can chlamydia diagnoses increase when their complications are declining?

Sexually Transmitted Infections

Volumn 81, Issue 4, 2005, Pages 285-286

  Cassell, J A ^a   Low, N ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER MORTALITY; CHLAMYDIASIS; EDITORIAL; GONORRHEA; HEALTH CARE FINANCING; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; SAFE SEX; UTERINE CERVIX CANCER;

EID: 23844554869     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2005.014902     Document Type: Editorial

References (20)

1. Egger M, Low N, Smith GD, et al. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998;316:1776-80.
2. Kamwendo F, Forslin L, Bodin L, et al. Programmes to reduce pelvic inflammatory disease-the Swedish experience. [Review] [39 refs]. Lancet 1998;351(Suppl 3):25-8.
3. Hillis SD, Nakashima A, Amsterdam L, et al. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plann Perspect 1995;27:108-11.
4. Susser M. The logic in ecological: I. The logic of analysis [see comments] [published erratum appears in Am J Public Health 1995;85(8 Pt 1):1063], Am J Public Health 1994;84:825-9.
5. Susser M. The logic in ecological: II. The logic of design [see comments]. Am J Public Health 1994;84:830-5.
6. Diez Roux A, Schwartz S, Susser E. Ecological variables, ecological studies, and multilevel studies in public health research. In: Detels R, McEwen J, Beaglehole R, Tanaka H, eds. Oxford textbook of public health. 4th ed. Oxford: Oxford University Press, 2004:493-507.
7. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-6.
8. Ostergaard L, Andersen B, Moller JK, et al. Home sampling versus conventional swab sampling for screening of chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis 2000;31:951-7.
9. Catchpole M, Robinson A, Temple A. Chlamydia screening in the United Kingdom. Sex Transm Infect 2003;79:3-4.
10. Stephenson JM. Screening for genital chlamydial infection. Br Med Bull 1998;54:891-902.
11. Westrom L. Decrease in incidence of women treated in hospital for acute salpingitis in Sweden. Genitourin Med 1988;64:59-63.
12. Nicoll A, Hughes G, Donnelly M, et al. Assessing the impact or national anti-HIV sexual health campaigns: trends in the transmission of HIV and other sexually transmitted infections in England. Sex Transm Infect 2001;77:242-7.
13. Coutinho RA, Rijsdijk AJ, van den Hoek JA, et al. Decreasing incidence of PID in Amsterdam. Genitourin Med 1992;68:353-5.
14. Low N, Harbord RM, Egger M, et al. Screening for chlamydia. Lancet 2005;365:1539.
15. Low N, Egger M. What should we do about screening for genital chlamydia? Int J Epidemiol 2002;31:891-3.
16. Beral V. Cancer of the cervix: a sexually transmitted infection? Lancet 1974;1:1037-40.
17. International Agency for Research on Cancer (IARC). Summaries and evaluations. Human papillomaviruses (HPV) (www.inchem.org/documents/iarc/vol64/ hpv, www inchem org/) Available from www.inchem.org/documents/iarc/vol64/hpv. html
18. Krieger N, Waterman PD, Chen JT, et al. Monitoring socioeconomic inequalities in sexually transmitted infections, tuberculosis, and violence: geocoding and choice of area-based socioeconomic measures-the public health disparities geocoding project (US). Public Health Rep 2003;118:240-60.
19. Koopman JS, Longini IM Jr. The ecological effects of individual exposures and nonlinear disease dynamics in populations. Am J Public Health 1994;84:836-42.
20. Diez Roux AV, Aiello AE. Multilevel analysis of infectious diseases. J Infect Dis 2005;191:525-33.